Literature DB >> 81502

Fundamental and clinical studies on new bleomycin analogs.

A Matsuda, O Yoshioka, T Yamashita, K Ebihara, H Umezawa, T Miura, K Katayama, M Yokoyama, S Nagai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 81502     DOI： 10.1007/978-3-642-81219-4_18

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN： 0080-0015


× No keyword cloud information.
  3 in total

1.  Occurrence of an anti-peplomycin IgE antibody cross-reacting with bleomycin in a patient with cervical uterine cancer.

Authors:  H Sakura; T Fujii; T Ohashi; S Tsuruta
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

2.  Peplomycin, a bleomycin derivative, induces myofibroblasts in pulmonary fibrosis.

Authors:  T Osaki; K Yoneda; Y Tatemoto; T Yamamoto; T Yokoyama; H Enzan
Journal:  Int J Exp Pathol       Date:  2001-08       Impact factor: 1.925

3.  Endoscopic local injection of a new drug delivery formulation, anticancer drug bound to carbon particles, for digestive cancers: pilot study.

Authors:  A Hagiwara; T Takahashi; K Kitamura; C Sakakura; M Shirasu; M Ohgaki; T Imanishi; J Yamasaki
Journal:  J Gastroenterol       Date:  1997-04       Impact factor: 7.527
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.